ENBI Share Price Performance
Recent ENBI News & Updates
No updates
Entheon Biomedical Corp. Key Details
Last Reported Earnings
May 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.026
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Entheon Biomedical Corp. Competitors
About ENBI
- Founded
- n/a
- Employees
- 1
- CEO
- WebsiteView website
Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Canadian Market Performance
- 7 Days: 0.4%
- 3 Months: 10.1%
- 1 Year: 17.4%
- Year to Date: 10.2%
The market has stayed flat over the 7 days. Meanwhile, the market is actually up 17% over the past year. Earnings are forecast to grow by 12% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading